See Why Coherus Stock Is Rising After Toripalimab Combination Trial In Lung Cancer
Shanghai Junshi Biosciences Co Ltd and Coherus BioSciences Inc (NASDAQ:CHRS) announced positive interim results from CHOICE-01 Phase 3 trial evaluating toripalimab plus chemotherapy…